Physician

John Stewart Jarboe, M.D., PHD

According to 2025 Medicare claims, John Jarboe, M.D., PHD (NPI: 1447662804) practices radiation oncology in the Montgomery, AL market, with the plurality of this provider's patient population coming from Montgomery, AL. This provider's primary affiliated billing organization is CENTRAL ALABAMA RADIATION ONCOLOGY (NPI: 1659644706; TIN: 454048337) and primary practice location at 36106-2801.

Jarboe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 246 traditional Medicare patients, billed 2,614 HCPCS/CPT codes, and received $467,817 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 377 prescription claims across 144 beneficiaries totaling $10,582 in drug costs, led by Mometasone Furoate (Mometasone Furoate). Open Payments data shows 9 records totaling $206. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $14,182 to $467,817. Similarly, Part D prescription costs have risen steadily, from $568 to $10,582. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	18	218	$14,182
2020	98	1,155	$178,584
2021	240	2,453	$434,832
2022	263	3,420	$571,823
2023	269	3,301	$550,573
2024	246	2,614	$467,817

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	20	42	$568
2016	N/R	N/R	N/R
2017	N/R	11	$4,837
2018	N/R	N/R	N/R
2019	12	17	$869
2020	15	32	$589
2021	53	131	$7,353
2022	84	203	$6,568
2023	125	336	$8,725
2024	144	377	$10,582

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	110	598	$261
77427	Radiation treatment management, 5 treatment sessions	67	159	$150
77014	Ct guidance for insertion of radiation therapy fields	95	468	$91
77336	Continuing radiation therapy consultation per week	77	174	$65
77300	Calculation of radiation therapy dose	47	216	$50

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mometasone Furoate	Mometasone Furoate	59	2,063	$2,228
Pentoxifylline	Pentoxifylline	52	2,010	$2,055
Dexamethasone	Dexamethasone	36	838	$983
Oxycodone Hcl	Oxycodone Hcl	13	127	$636
Memantine Hcl	Memantine Hcl	17	603	$570

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$206	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Stewart Jarboe, M.D., PHD?

Tedicare shows public-source Medicare data for John Stewart Jarboe, M.D., PHD (NPI 1447662804), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Stewart Jarboe, M.D., PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Stewart Jarboe, M.D., PHD?

John Stewart Jarboe, M.D., PHD is linked to CENTRAL ALABAMA RADIATION ONCOLOGY (billing NPI 1659644706) in the available physician profile data.

Does John Stewart Jarboe, M.D., PHD have Open Payments data?

John Stewart Jarboe, M.D., PHD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.